The Patient Signal

In this episode, we explore a range of recent developments in healthcare and technology: 1. A study highlights the positive impact of Medicaid expansion on lung cancer survival rates, emphasizing the importance of healthcare accessibility. 2. Mavacamten shows promise in treating pediatric obstructive hypertrophic cardiomyopathy, offering a potential new therapeutic option for children. 3. The clinical trial landscape is evolving with platformization and AI, leading to more efficient and patient-centric trials. 4. Medtronic's MiniMed Go app, designed to enhance glycemic control, receives FDA clearance, marking a step forward in diabetes management. 5. CareDx and 10x Genomics launch ImmuneScape, a program aimed at understanding transplant rejection through advanced multiomics. 6. Ro partners with Amgen to improve access to GLP-1 medications, addressing barriers to obesity care. 7. ACA enrollment for 2026 is slower, impacted by premium increases, yet remains higher than expected. 8. Digital health funding surges in 2025, driven by AI investments, despite challenges in the sector. 9. Pharmacy closures affect healthcare delivery, especially in rural areas, highlighting the need for policy interventions. 10. Anthropic introduces Claude for Healthcare, an AI tool suite to reduce administrative burdens and enhance patient care. 11. Asimov and AGC Biologics collaborate on a new viral vector production approach, simplifying the process and reducing costs. 12. A study finds TikTok videos by physicians more reliable for breast cancer prevention, stressing the importance of sourcing medical information from professionals. 13. Nemours Children's Health launches the Advanced Care at Home program, reducing hospital stays and improving outcomes for children. 14. Researchers explore automated models to improve CT scan efficiency, reducing radiation exposure and enhancing diagnostic accuracy. Stan Berteloot is a French-American journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! Stan Berteloot is a French-American journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! 📚 Sources: https://www.managedhealthcareexecutive.com/view/patient-facing-ehr-tool-improves-lung-cancer-screening-identification https://www.drugtopics.com/view/impact-of-pharmacy-closures-reaches-far-beyond-medication-access https://www.appliedclinicaltrialsonline.com/view/trial-competition-slows-ai-gains-rethinking-patient-level-safety-decisions-real-ai-platforms-clinical-trials https://www.medtechdive.com/news/medtronic-clearance-insulin-pen-app-abbott/809479/ https://www.mobihealthnews.com/news/caredx-10x-genomics-partner-decode-transplant-rejection-cellular-resolution https://www.biospace.com/press-releases/ro-announces-research-collaboration-to-better-understand-and-improve-the-real-world-patient-experience-with-glp-1s https://www.healthcaredive.com/news/aca-enrollment-2026-cms-obamacare-snapshot/809445/ https://www.healthcaredive.com/news/digital-health-funding-2025-boosted-ai-rock-health/809449/ https://www.drugtopics.com/view/mavacamten-shows-improvements-for-pediatric-obstructive-hypertrophic-cardiomyopathy https://www.appliedclinicaltrialsonline.com/view/clinical-trials-2026-platformization-ai-fluency-value-chain https://pharmaphorum.com/news/jpm-anthropic-reveals-its-answer-chatgpt-health

In this episode, we explore key developments from the JPMorgan Healthcare Conference, where biotech companies made waves despite the lack of major announcements, highlighting the sector's ongoing growth potential. Chai Discovery's collaboration with Eli Lilly aims to enhance biologics discovery using AI, following a successful Series B funding round. VieCure secured $43 million to expand its AI-powered Halo Intelligence platform, emphasizing democratizing precision medicine. Applied Clinical Trials Online discusses the role of digital technologies in clinical trials, while NVIDIA's partnerships with Eli Lilly and Thermo Fisher aim to integrate AI into drug discovery and laboratory operations. NEJM AI examines cognitive biases in AI systems, stressing the need for fair and accurate applications. The New England Journal of Medicine highlights ethical considerations in medical AI, and JAMA Network Open evaluates AI's reliability in providing nutritional information. Finally, NVIDIA and Eli Lilly's $1 billion investment in an AI co-innovation lab promises to revolutionize drug discovery and manufacturing processes. Stan Berteloot is a French-American journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! Stan Berteloot is a French-American journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! 📚 Sources: https://www.statnews.com/2026/01/12/noubar-afeyan-letter-investors-jpm-2026/ https://www.biospace.com/press-releases/chai-discovery-announces-collaboration-with-eli-lilly-and-company-to-accelerate-biologics-discovery https://www.mobihealthnews.com/news/viecure-raises-43m-cancer-care-platform https://www.appliedclinicaltrialsonline.com/ https://pharmaphorum.com/news/nvidia-announces-lily-thermo-fisher-partnerships-jpm https://ai.nejm.org/doi/abs/10.1056/AIcs2400639 https://www.nejm.org/doi/full/10.1056/NEJMra2214183 https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2813295 https://hitconsultant.net/2026/01/12/nvidia-and-eli-lilly-launch-ai-co-innovation-lab-to-reinvent-drug-discovery/

In this episode, we explore how data, AI, and capital are transforming the life sciences industry as 2026 begins. We start with Accenture and Salesforce's new AI-powered life sciences cloud, designed to streamline operations and improve decision-making. Next, we discuss Alexandra Beneville's appointment at Phreesia, enhancing their life sciences content strategy. We then highlight a company's expanded AI partnership to accelerate clinical development. Eytan Ellenberg delves into the complexities of drug causality, while Haisco Pharmaceutical's AirNexis spinout targets the Western market with a new respiratory treatment. We also cover a study favoring risk-based breast cancer screening over traditional methods. Finally, we examine the $4.9 billion funding surge in biotech as the J.P. Morgan Healthcare Conference approaches. Stan Berteloot is a French-American journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! Stan Berteloot is a French-American journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! 📚 Sources: https://www.fiercebiotech.com/medtech/accenture-joins-salesforce-build-out-ai-powered-cloud-service-life-sciences-companies https://www.mmm-online.com/home/channel/phreesia-appoints-alexandra-beneville-vp-of-life-sciences-content-strategy https://www.appliedclinicaltrialsonline.com/view/medidata-biorender-announce-new-ai-partnerships-expanding-capabilities-life-sciences https://www.appliedclinicaltrialsonline.com/view/conference-calls-for-unity-in-addressing-artificial-intelligence-regulation-in-life-sciences-research-and-development https://www.biocentury.com/article/658026/haisco-steps-onto-global-stage-with-blue-chip-newco-deal https://www.managedhealthcareexecutive.com/view/top-3-opportunities-artificial-intelligence-healthcare https://endpoints.news/private-and-public-biotechs-go-on-4-8b-funding-spree-ahead-of-jpm/

In this episode, we explore the FDA's new guidance exempting certain wellness features and clinical decision support tools from medical device oversight, fostering innovation in wearables and software. We also delve into the role of AI in pharmaceutical customer relations, highlighting the need for seamless integration to enhance sales and support. Eli Lilly's acquisition of Ventyx Biosciences marks a significant expansion in immunology, while the biopharma industry sees a strategic focus on metabolic medicines despite fewer partnerships. Color Health's collaboration with Evry Health aims to integrate cancer care into employer health plans, and PwC calls for a reinvention in biopharma to stay competitive. Adam Feuerstein reports on the biotech industry's maturation, and Sam Ash emphasizes careful AI implementation in healthcare. Tensive Srl's bioabsorbable breast implant shows promising trial results, and Boltz PBC launches to democratize AI in drug discovery. Parabilis Medicines secures funding for desmoid tumor treatments, and venture capital in healthcare increasingly focuses on AI integration. Finally, collaborations like Anthropic with Genmab and Hippocratic AI with Boston Consulting Group highlight AI's growing role in healthcare innovation, while AI's impact on oral surgery diagnostics is explored in the British Dental Journal. Stan Berteloot is a French journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! Stan Berteloot is a French journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! 📚 Sources: https://www.medtechdive.com/news/fda-exempts-wearable-ai-features-guidance/809099/ https://medcitynews.com/2026/01/pharmas-make-or-break-moment-how-ai-is-rewriting-the-rules-of-customer-engagement/ https://medcitynews.com/2026/01/eli-lilly-ventyx-biosciences-acquisition-nlrp3-inhibitor-inflammation-vtyx-lly/ https://medcitynews.com/2026/01/j-p-morgan-report-obesity-diabetes-dealmaking-set-a-new-record-in-2025/ https://medcitynews.com/2026/01/color-health-partners-with-evry-health-to-expand-access-to-virtual-cancer-care/ https://www.fiercebiotech.com/biotech/build-future-pharmas-must-embrace-ai-patient-experience-and-new-rd-frontiers-pwc https://www.statnews.com/2026/01/08/ocular-therapeutix-wet-amd-axpaxli/ https://www.beckershospitalreview.com/healthcare-information-technology/ai/why-some-cios-are-reining-in-ai/ https://www.bioworld.com/topics/85-bioworld-medtech https://www.genengnews.com/topics/artificial-intelligence/boltz-pbc-launches-with-28m-to-democratize-ai-platforms-for-drug-discovery/ https://pharmaphorum.com/news/parabilis-scores-305m-bumper-biofinancing-week https://hitconsultant.net/2026/01/09/the-flight-to-quality-why-2026-healthcare-vc-is-betting-on-ai-integration-over-innovation/ https://www.mobihealthnews.com/news/anthropic-genmab-partner-use-claude-rd-and-more-digital-health-news https://www.nature.com/articles/s41415-025-9509-2 ...

Welcome to today's episode, where we explore the latest in health and technology. OpenAI has launched ChatGPT Health, a new feature designed to integrate personal health information with AI, helping users manage their health more effectively. This innovation reflects a growing trend in healthcare towards using advanced technologies to enhance patient care. In other news, Surgerii Robotics, a Chinese surgical robot manufacturer, has raised $100 million to expand the global reach of its SHURUI single port endoscopic surgical robot. This advancement highlights the competitive landscape of robotic surgery, with Surgerii competing against major players like Intuitive Surgical. Shifting to public health, concerns have arisen over potential conflicts of interest as a panel developing new dietary guidelines has financial ties to the beef and dairy industries. This situation raises questions about the integrity and transparency of these influential recommendations. In the pharmaceutical sector, Eli Lilly is acquiring Ventyx Biosciences for $1.2 billion to bolster its focus on oral immune drugs targeting inflammatory conditions. This acquisition enhances Lilly's portfolio in obesity and metabolic treatments. Lastly, AI-driven drug discovery company Earendil has secured a $2 billion deal with Sanofi, emphasizing the growing role of AI in the pharmaceutical industry. This partnership aims to accelerate drug discovery, showcasing AI's potential to revolutionize the development of new therapies. Stay tuned for more insights and updates on the intersection of technology and health. Stan Berteloot is a French journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! Stan Berteloot is a French journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! 📚 Sources: https://medcitynews.com/2026/01/openai-chatgpt-healthcare-privacy-data/ https://www.medtechdive.com/news/Surgerii-Robotics-raises-100M-fund-global-expansion/809056/ https://www.statnews.com/2026/01/06/fda-pulls-back-oversight-ai-enabled-devices-wearables/?utm_campaign=rss https://www.biopharmadive.com/news/lilly-ventyx-acquire-deal-nlrp3-inflammasome/808988/ https://www.bioworld.com/articles/727792-ai-drug-discovery-brings-2b-sanofi-deal-to-1-year-old-earendil

In this episode, we delve into recent developments in politics, health care, and technology. Former President Donald Trump has called on Republicans to adopt a more flexible approach to abortion restrictions to secure a health care deal, emphasizing the need for compromise to achieve broader legislative goals. Meanwhile, Biobeat Technologies has raised $50 million to introduce its innovative cuffless blood pressure monitor to the U.S. market, despite skepticism from cardiovascular health bodies. Lastly, Insilico Medicine has partnered with Servier in a groundbreaking $888 million collaboration to leverage AI for drug discovery, highlighting the growing role of technology in the pharmaceutical industry. Join us as we explore these stories and their implications for the future. Stan Berteloot is a French journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! Stan Berteloot is a French journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! 📚 Sources: https://www.statnews.com/2026/01/06/fda-pulls-back-oversight-ai-enabled-devices-wearables/?utm_campaign=rss https://www.medtechdive.com/news/biobeat-raises-50m-cuffless-blood-pressure/808817/ https://www.bioworld.com/articles/727787-insilico-inks-888m-drug-discovery-partnership-with-servier

In this episode, we explore President Donald Trump's recent executive order establishing a unified national policy for AI development, aiming to override various state regulations. This move seeks to address concerns from health IT companies about inconsistent state laws, promoting a cohesive strategy across the healthcare sector. We also delve into the biotech sector, where Adam Feuerstein outlines 26 key stock-moving events for the first quarter of 2026, highlighting pivotal trial results and regulatory decisions that could reshape the industry. Additionally, we discuss the evolution of AI in healthcare, with Agentic AI transitioning from standalone models to "digital co-workers," potentially easing clinician burnout. Finally, we cover the American Medical Association's call for Congress to make permanent the Medicare telehealth flexibilities introduced during the Covid-19 pandemic, emphasizing the need for stable telehealth access for Medicare beneficiaries. Stan Berteloot is a French journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! Stan Berteloot is a French journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! 📚 Sources: https://www.healthcareitnews.com/news/health-it-companies-seek-clearer-more-consistent-rules-ai-development https://www.statnews.com/2026/01/05/neuralink-brain-computer-interface-medical-device-vs-transhumanism/ https://medcitynews.com/2026/01/healthcare-ai-agent/ https://medcitynews.com/2026/01/ama-to-congress-make-medicare-telehealth-services-permanent/

In this episode, we explore the transformative role of AI in the pharmaceutical industry, highlighting Insilico Medicine's Rentosertib, the first AI-discovered drug poised for Phase 3 clinical trials. With AI investments projected to reach $16.49 billion by 2034, industry leaders like Eli Lilly are at the forefront, collaborating with tech giants to revolutionize drug discovery. Despite AI's promise, experts caution about its limitations in human trials. We also delve into the challenges hospitals face with new medical technology, likening it to a prisoner's dilemma. While robotic systems promise improved care, the costs and rapid tech advancements pose strategic dilemmas for healthcare providers. Lastly, we discuss the DEA's extension of telemedicine prescribing flexibilities through 2026, a move applauded by telehealth advocates. This extension aims to ensure continued access to care while balancing human expertise with technology in healthcare practices. Join Stan Berteloot, a French journalist and AI expert, as he navigates these intersections of technology and culture. As Head of Strategy and CTO at Nytro Marketing, Stan brings insights from his AI-driven content creation initiatives and his podcast, Back in America. Stan Berteloot is a French journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! Stan Berteloot is a French journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! 📚 Sources: https://qz.com/pharma-ai-research-progress-lilly-insilico https://www.statnews.com/2026/01/02/hospitals-robots-training-prisoners-dilemma/ https://medcitynews.com/2026/01/extension-remote-prescribing-flexibilities/

In this episode, we delve into the recent appointment of a key adviser to Robert F. Kennedy Jr. on vaccine policy to the CDC, marking a significant shift in the agency's approach to children's health research. This move could signal a broadening of perspectives within the CDC, as the adviser, known for challenging mainstream vaccine consensus, steps into a new role focused on improving health outcomes for children. We also highlight three major public health issues to watch in 2026: the ongoing battle against infectious diseases, the growing focus on mental health integration into primary care, and the rising concern of climate change's impact on public health. These topics underscore the need for resilient health systems and collaborative efforts to ensure equitable access to care. Stan Berteloot is a French journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! Stan Berteloot is a French journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! 📚 Sources: https://www.statnews.com/2025/12/27/nih-neurological-disorders-stroke-institute-director-koroshetz-ousted/ https://www.statnews.com/2025/12/26/public-health-2026-issues-to-watch/?utm_campaign=rss

This episode moves from brand strategy to public health strategy, and shows how leadership choices ripple through both worlds. We start with Kenvue’s global agency shakeup, bringing WPP and Publicis into clearly defined lanes as the company looks to streamline execution and push growth across a $1.6B ad footprint. Then we zoom out to 2026’s vaccine reality: mandates, access, and the race to develop new vaccines, all colliding with politics, logistics, and trust. From there, we connect the dots to a year of medtech turbulence: lawsuits, ERP failures, M&A, leadership turnovers, layoffs, and regulatory pressure shaping how companies operate. Finally, we end with a concrete medical milestone: the first FDA-approved treatment for TA-TMA, a rare and severe complication after stem cell transplants, and what it signals about the future of targeted therapies. In this episode: • Why Kenvue’s partner model matters for speed, accountability, and scale • What vaccine policy fights reveal about trust and governance • The medtech stories that defined 2025’s risk landscape • A breakthrough FDA approval that could change outcomes for transplant patients Thanks for listening to this episode. We also discuss the challenges facing vaccine policy in 2026, including debates over mandates, distribution to underserved communities, and the development of new vaccines for emerging diseases. In the medtech industry, 2025 was marked by significant changes, such as Zimmer Biomet's lawsuit against Deloitte and Johnson & Johnson's major acquisitions. Leadership shifts and strategic refocusing were prevalent, with companies like Olympus and Medtronic adapting to evolving market demands. Finally, we highlight Omeros's groundbreaking FDA-approved treatment for a severe stem cell transplant complication, showcasing the potential of targeted therapies in addressing complex medical challenges. Join us as we navigate these dynamic stories and their implications for the future. Stan Berteloot is a French journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! Stan Berteloot is a French journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! 📚 Sources: https://www.mmm-online.com/news/kenvue-assigns-global-creative-duties-to-wpp-and-media-to-publicis/ https://www.statnews.com/2025/12/26/best-of-2025-health-science-biotech/ https://www.massdevice.com/the-10-most-read-medtech-news-stories-of-2025/ https://medcitynews.com/2025/12/fatal-complication-of-stem-cell-transplants-gets-its-first-fda-approved-therapy/

Welcome to the Legaltech News Podcast, where we delve into the dynamic intersection of law and technology. Stay informed with our expert analysis on the latest trends in legal tech, from AI integration in legal processes to tackling cybersecurity threats. Discover how legal departments can boost efficiency and cut costs, while law firms enhance client services with innovative tools. We also spotlight tech companies driving change in the legal sector. In today's episode, we explore Dr. Thomas Kelly's inspiring journey from medicine to legaltech innovation. After leaving his medical career, Kelly developed AI tools like Heidi, an AI medical scribe, to ease doctors' administrative burdens. His venture has attracted significant funding, highlighting AI's transformative potential in traditional fields. Join us as we provide the insights you need to navigate the rapidly evolving legal tech landscape and make informed decisions. Stan Berteloot is a French journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! Stan Berteloot is a French journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! 📚 Sources: https://www.law.com/2025/12/24/health-care-and-life-science-stakeholders-value-ai-for-regulatory-monitoring/ https://www.cnbc.com/2025/12/24/he-left-medicine-to-build-an-ai-tool-now-its-worth-460-million.html

In this episode, we explore the latest developments in the pharmaceutical and healthcare sectors. The FDA has approved an oral version of Novo Nordisk’s Wegovy, potentially increasing accessibility for patients seeking weight-loss solutions. The pharmaceutical industry is undergoing significant changes, with major mergers and regulatory shifts shaping its future. Medicus Pharma Ltd. is collaborating with Reliant AI Inc. to enhance clinical trial efficiency through AI-driven analytics. The U.S. government is leveraging AI for biotech and biodefense advancements, raising biosecurity concerns. The FDA is integrating AI to streamline operations and improve decision-making. Medtech mergers and acquisitions are expected to accelerate, focusing on AI and data-driven capabilities. Chai has secured $130 million to advance AI-driven drug discovery, aiming to revolutionize healthcare. A controversial cancer diet is being reconsidered for its potential benefits, sparking debate among medical professionals. The FDA is addressing AI monitoring in medical devices, emphasizing real-world performance. Lastly, Kaiser Permanente successfully consolidated its electronic health record systems, setting a precedent for future health system projects. Stan Berteloot is a French journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! Stan Berteloot is a French journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! 📚 Sources: https://www.statnews.com/2025/12/22/hhs-proposes-scrapping-ai-model-cards-transparency-rule/ https://www.mmm-online.com/news/2025-the-year-in-pharma-tariffs-mergers-and-regulatory-volatility/ https://drug-dev.com/medicus-pharma-announces-engagement-with-reliant-ai-to-develop-ai-driven-clinical-data-analytics-platform/ https://councilonstrategicrisks.org/2025/12/22/2025-aixbio-wrapped-a-year-in-review-and-projections-for-2026/ https://www.fiercebiotech.com/ai-and-machine-learning/fda-adopts-agentic-ai-latest-push-infuse-agency-artificial-intelligence https://www.medtechdive.com/news/pitchbook-merger-acquisition-acceleration-2026/806872/ https://www.fiercebiotech.com/biotech/chai-infuses-ai-drug-discovery-efforts-130m-series-b https://www.statnews.com/2025/12/15/mammogram-ai-predictive-models-both-breast-cancer-heart-disease/ https://www.medtechdive.com/news/fda-comments-ai-performance-monitoring/807995/ https://medcitynews.com/2025/12/kaiser-permanente-ehr/

Welcome to the AI in Healthcare podcast, where we explore the transformative impact of artificial intelligence on the medical industry. AI is rapidly reshaping healthcare, with a projected compound annual growth rate of 38.6% driven by deep learning, remote monitoring, and chronic care management. McKinsey & Company highlights the role of generative AI in streamlining back-office tasks like claims processing. AI is enhancing patient care by improving clinical workflows and patient interactions through chatbots, while also boosting clinician productivity with documentation and decision support tools. In diagnostics, AI-powered imaging tools are reducing errors, and robot-assisted surgeries are offering minimally invasive options. AI is also personalizing physical therapy and optimizing supply chain management through predictive analytics. However, equitable access to AI tools remains a concern, especially for smaller practices. The medtech industry is undergoing significant changes, with AI and robotics enhancing diagnostic accuracy and surgical procedures. The FDA is seeing a surge in AI-enabled medical device approvals, with 235 devices authorized in 2024 alone. AI's role in predictive analytics is growing, allowing for earlier disease detection and personalized treatments. The integration of AI in healthcare is fostering a shift towards patient-centric care models, emphasizing preventive measures and remote monitoring. AI is revolutionizing the medical technology industry by streamlining research and development, optimizing manufacturing processes, and transforming marketing and sales strategies. As AI becomes integral to healthcare, it offers faster, data-driven insights that improve patient outcomes and operational efficiency. This technological shift is set to redefine the healthcare industry, making it more responsive and patient-centered. Source URLs https://www.techtarget.com/searchHealthIT/feature/AI-healthcare-trends-to-watch https://www.zs.com/insights/medtech-trends-2025-healthcare-innovation https://www.medtechdive.com/news/ai-medtech-track-new-devices-fda/748397/ https://api4.ai/blog/top-10-ai-trends-shaping-the-healthcare-and-medical-industry-in-2025 https://www.scalacode.com/guides/ai-in-healthcare/ https://www.porsche-consulting.com/international/en/article/artificial-intelligence-medical-technology Join Stan Berteloot, a French journalist and AI expert, as he delves into these stories and more, exploring the intersection of technology and healthcare. Stan Berteloot is a French journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! Stan Berteloot is a French journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today!

This episode of 'AI in Life Sciences' presents exciting updates from the world of artificial intelligence and its game-changing applications in the Life Sciences sector. Pioneering the breakthroughs, in our first news item, Seven AI has garnered an impressive $36 million in initial funding. This considerable investment will bolster the tech company's ambition to equip businesses with AI-powered cybersecurity. As cyber threats grow more sophisticated, Seven AI's adaptive software is a remarkable step towards empowering digital defenses. Notably, Greylock took the lead in this round, boosting the cybersecurity company's value to over $100 million.

"AI in Life Sciences" dives into the world where technology and biology intersect, providing expert insight and analysis on the latest trends, breakthroughs, and controversies. In this episode, we explore a potential bird flu threat in Midwestern milk, the innovative use of AI in tackling workforce shortages in healthcare, and impressive revenue growth in AstraZeneca, thanks in part to their cancer drugs. We also discuss Regeneron Pharmaceuticals’ $100M wager on Mammoth’s CRISPR technology, the crucial role of AI understanding for health IT leaders, and how AI is revolutionizing drug discovery at AION Labs. Finally, we delve into Bristol Myers Squibb’s major restructuring and its implications for employees and the company's future growth. Stay tuned for these stories and more on "AI in Life Sciences".

AI in Life Sciences is a podcast that keeps a finger on the pulse of technological advancement within the healthcare and pharmaceutical fields. In this episode, we'll take a deep dive into Novartis AG's recent nomination of former Bristol Myers CEO Giovanni Caforio as incoming chair, examining what this could mean for the company's future amidst the global competition. We'll then switch gears to discuss the ongoing reorganization of AI-driven drug developer, BenevolentAI, and how shifting priorities are impacting its workforce. The episode will also cover Ultrahuman's anticipated expansion into the US market through the establishment of a manufacturing center in Indiana, a move benefiting domestic production and job creation. Finally, we'll review Basware's new AP Protect tool, designed to detect errors and fraudulent activities in finance teams using advanced AI algorithms. Join us for thought-provoking insights into how AI continues to revolutionize the life sciences sector.

"AI in Life Sciences" explores the intersect of artificial intelligence (AI) and healthcare this week. We start with a discussion on the ABOUT Healthcare's merger with Edgility which it is hoped will usher in a new era of care orchestration solutions, utilizing AI and predictive analytics to optimize hospital operations and improve patient care. We then celebrate an unprecedented regulatory move in blood disorder diagnosis with Scopio Labs' FDA De Novo clearance for its Full-Field Bone Marrow Aspirate (FF-BMA) Application, a software that digitizes the analysis of bone marrow aspirate with the help of AI. Our next story analyses the abilities of Innovaccer's latest healthcare data activation platform, HXP. Born after Innovaccer's acquisition of Cured, this platform uses AI to engage patients and expedite revenue growth. Finally, we wrap up with new developments at GE HealthCare, which recently launched Voluson Signature ultrasound systems that fuse ergonomics with AI, aimed at improving women's healthcare. Tune in to stay updated on how AI continues to refine and revolutionize the healthcare industry.

"AI in Life Sciences" takes a comprehensive look into how artificial intelligence is revolutionizing healthcare and life sciences. It covers various developments and innovations in healthcare from an AI perspective. In this episode, we discuss how AI is being used by Johns Hopkins to predict supply needs which could potentially revolutionize industry practices. We examine the role of GLP-1 molecules in Parkinson's treatment and how de-extinct species could impact medical research. Shining a spotlight on the troubling divide in the healthcare sector between payers and providers, we discuss its implications and possible solutions. Lastly, we delve into the case of Philadelphia's Safehouse and its setback after a federal judge ruled against their appeal, which could impact the fight against the city's opioid crisis. Tune in to discover more about these captivating topics.

"AI in Life Sciences" is an intriguing podcast that presents the latest advancements of AI and tech in the health sciences. This episode discusses HeHealth's cutting-edge STI detection tool, the challenge of patient identification and how Healthix is solving this using Verato, Eko Health's AI-enabled cardiac tool which has recently received FDA clearance, the use of machine learning techniques to tailor personalized medicine treatments, and the inclusion of VR technology in nursing education, including discussion on the barriers and potential solutions for its wider adoption. Tune in to understand the future of technology in healthcare.

AI in Life Sciences is a cutting-edge podcast, offering you the latest insights into the application of artificial intelligence in the life sciences sector. This week we delve into Integra LifeSciences' lucrative acquisition of Acclarent, a pioneer in ENT surgical interventions, looking at the diverse market opportunities that this presents. We also discuss the role of quality data in improving the effectiveness of AI models in healthcare. The podcast features an insightful segment on the tripartite partnership of Otsuka Pharmaceutical, Click Therapeutics, and the FDA leading to the clearance of a new digital therapeutic for major depressive disorder. Our episode also examines the National Institutes of Health's initiative to fund the development of AI tools to aid health disparity research. We explore how AI is potentially transforming healthcare, and how we need to prepare healthcare professionals to leverage these advancements. Finally, we delve into how innovative technology and automation, led by Norbert Health's AI sensing hub, are changing the face of elder care. Tune in for these exciting developments and much more.